Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02581631
Title A Safety and Efficacy Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas (CheckMate 436)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

Sezary's disease

peripheral T-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Brentuximab vedotin + Nivolumab

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN


No variant requirements are available.